Report Detail
Global (United States, European Union and China) Oral Contrast Agent Market Research Report 2019-2025
- RnM3369041 |
- 14 July, 2020 |
- Global |
- 115 Pages |
- QYResearch |
- Pharma & Healthcare
Oral Contrast Agent market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Oral Contrast Agent market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Oral Contrast Agent market is segmented into
Barium-based Contrast Media
Iodinated Contrast Media
Gadolinium-based Contrast Media
Microbubble Contrast Media
Segment by Application, the Oral Contrast Agent market is segmented into
Cardiovascular Disorders
Cancer
Gastrointestinal Disorders
Musculoskeletal Disorders
Neurological Disorders
Nephrological Disorders
Regional and Country-level Analysis
The Oral Contrast Agent market is analysed and market size information is provided by regions (countries).
The key regions covered in the Oral Contrast Agent market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Oral Contrast Agent Market Share Analysis
Oral Contrast Agent market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Oral Contrast Agent business, the date to enter into the Oral Contrast Agent market, Oral Contrast Agent product introduction, recent developments, etc.
The major vendors covered:
GE Healthcare (US)
Bracco Imaging (Italy)
Bayer HealthCare (Germany)
Guerbet (France)
Lantheus (US)
Daiichi Sankyo (Japan)
Unijules Life Sciences (India)
J.B. Chemicals and Pharmaceuticals (India)
Spago Nanomedicine (Sweden)
Taejoon Pharm (South Korea)
Jodas (India)
Magnus Health (India)
1 Study Coverage
- 1.1 Oral Contrast Agent Product Introduction
- 1.2 Market Segments
- 1.3 Key Oral Contrast Agent Manufacturers Covered: Ranking by Revenue
- 1.4 Market by Type
- 1.4.1 Global Oral Contrast Agent Market Size Growth Rate by Type
- 1.4.2 Barium-based Contrast Media
- 1.4.3 Iodinated Contrast Media
- 1.4.4 Gadolinium-based Contrast Media
- 1.4.5 Microbubble Contrast Media
- 1.5 Market by Application
- 1.5.1 Global Oral Contrast Agent Market Size Growth Rate by Application
- 1.5.2 Cardiovascular Disorders
- 1.5.3 Cancer
- 1.5.4 Gastrointestinal Disorders
- 1.5.5 Musculoskeletal Disorders
- 1.5.6 Neurological Disorders
- 1.5.7 Nephrological Disorders
- 1.6 Study Objectives
- 1.7 Years Considered
2 Executive Summary
- 2.1 Global Oral Contrast Agent Market Size, Estimates and Forecasts
- 2.1.1 Global Oral Contrast Agent Revenue 2015-2026
- 2.1.2 Global Oral Contrast Agent Sales 2015-2026
- 2.2 Global Oral Contrast Agent, Market Size by Producing Regions: 2015 VS 2020 VS 2026
- 2.2.1 Global Oral Contrast Agent Retrospective Market Scenario in Sales by Region: 2015-2020
- 2.2.2 Global Oral Contrast Agent Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Oral Contrast Agent Competitor Landscape by Players
- 3.1 Oral Contrast Agent Sales by Manufacturers
- 3.1.1 Oral Contrast Agent Sales by Manufacturers (2015-2020)
- 3.1.2 Oral Contrast Agent Sales Market Share by Manufacturers (2015-2020)
- 3.2 Oral Contrast Agent Revenue by Manufacturers
- 3.2.1 Oral Contrast Agent Revenue by Manufacturers (2015-2020)
- 3.2.2 Oral Contrast Agent Revenue Share by Manufacturers (2015-2020)
- 3.2.3 Global Oral Contrast Agent Market Concentration Ratio (CR5 and HHI) (2015-2020)
- 3.2.4 Global Top 10 and Top 5 Companies by Oral Contrast Agent Revenue in 2019
- 3.2.5 Global Oral Contrast Agent Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
- 3.3 Oral Contrast Agent Price by Manufacturers
- 3.4 Oral Contrast Agent Manufacturing Base Distribution, Product Types
- 3.4.1 Oral Contrast Agent Manufacturers Manufacturing Base Distribution, Headquarters
- 3.4.2 Manufacturers Oral Contrast Agent Product Type
- 3.4.3 Date of International Manufacturers Enter into Oral Contrast Agent Market
- 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
- 4.1 Global Oral Contrast Agent Market Size by Type (2015-2020)
- 4.1.1 Global Oral Contrast Agent Sales by Type (2015-2020)
- 4.1.2 Global Oral Contrast Agent Revenue by Type (2015-2020)
- 4.1.3 Oral Contrast Agent Average Selling Price (ASP) by Type (2015-2026)
- 4.2 Global Oral Contrast Agent Market Size Forecast by Type (2021-2026)
- 4.2.1 Global Oral Contrast Agent Sales Forecast by Type (2021-2026)
- 4.2.2 Global Oral Contrast Agent Revenue Forecast by Type (2021-2026)
- 4.2.3 Oral Contrast Agent Average Selling Price (ASP) Forecast by Type (2021-2026)
- 4.3 Global Oral Contrast Agent Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
- 5.1 Global Oral Contrast Agent Market Size by Application (2015-2020)
- 5.1.1 Global Oral Contrast Agent Sales by Application (2015-2020)
- 5.1.2 Global Oral Contrast Agent Revenue by Application (2015-2020)
- 5.1.3 Oral Contrast Agent Price by Application (2015-2020)
- 5.2 Oral Contrast Agent Market Size Forecast by Application (2021-2026)
- 5.2.1 Global Oral Contrast Agent Sales Forecast by Application (2021-2026)
- 5.2.2 Global Oral Contrast Agent Revenue Forecast by Application (2021-2026)
- 5.2.3 Global Oral Contrast Agent Price Forecast by Application (2021-2026)
6 North America
- 6.1 North America Oral Contrast Agent by Country
- 6.1.1 North America Oral Contrast Agent Sales by Country
- 6.1.2 North America Oral Contrast Agent Revenue by Country
- 6.1.3 U.S.
- 6.1.4 Canada
- 6.2 North America Oral Contrast Agent Market Facts & Figures by Type
- 6.3 North America Oral Contrast Agent Market Facts & Figures by Application
7 Europe
- 7.1 Europe Oral Contrast Agent by Country
- 7.1.1 Europe Oral Contrast Agent Sales by Country
- 7.1.2 Europe Oral Contrast Agent Revenue by Country
- 7.1.3 Germany
- 7.1.4 France
- 7.1.5 U.K.
- 7.1.6 Italy
- 7.1.7 Russia
- 7.2 Europe Oral Contrast Agent Market Facts & Figures by Type
- 7.3 Europe Oral Contrast Agent Market Facts & Figures by Application
8 Asia Pacific
- 8.1 Asia Pacific Oral Contrast Agent by Region
- 8.1.1 Asia Pacific Oral Contrast Agent Sales by Region
- 8.1.2 Asia Pacific Oral Contrast Agent Revenue by Region
- 8.1.3 China
- 8.1.4 Japan
- 8.1.5 South Korea
- 8.1.6 India
- 8.1.7 Australia
- 8.1.8 Taiwan
- 8.1.9 Indonesia
- 8.1.10 Thailand
- 8.1.11 Malaysia
- 8.1.12 Philippines
- 8.1.13 Vietnam
- 8.2 Asia Pacific Oral Contrast Agent Market Facts & Figures by Type
- 8.3 Asia Pacific Oral Contrast Agent Market Facts & Figures by Application
9 Latin America
- 9.1 Latin America Oral Contrast Agent by Country
- 9.1.1 Latin America Oral Contrast Agent Sales by Country
- 9.1.2 Latin America Oral Contrast Agent Revenue by Country
- 9.1.3 Mexico
- 9.1.4 Brazil
- 9.1.5 Argentina
- 9.2 Central & South America Oral Contrast Agent Market Facts & Figures by Type
- 9.3 Central & South America Oral Contrast Agent Market Facts & Figures by Application
10 Middle East and Africa
- 10.1 Middle East and Africa Oral Contrast Agent by Country
- 10.1.1 Middle East and Africa Oral Contrast Agent Sales by Country
- 10.1.2 Middle East and Africa Oral Contrast Agent Revenue by Country
- 10.1.3 Turkey
- 10.1.4 Saudi Arabia
- 10.1.5 U.A.E
- 10.2 Middle East and Africa Oral Contrast Agent Market Facts & Figures by Type
- 10.3 Middle East and Africa Oral Contrast Agent Market Facts & Figures by Application
11 Company Profiles
- 11.1 GE Healthcare (US)
- 11.1.1 GE Healthcare (US) Corporation Information
- 11.1.2 GE Healthcare (US) Description and Business Overview
- 11.1.3 GE Healthcare (US) Sales, Revenue and Gross Margin (2015-2020)
- 11.1.4 GE Healthcare (US) Oral Contrast Agent Products Offered
- 11.1.5 GE Healthcare (US) Related Developments
- 11.2 Bracco Imaging (Italy)
- 11.2.1 Bracco Imaging (Italy) Corporation Information
- 11.2.2 Bracco Imaging (Italy) Description and Business Overview
- 11.2.3 Bracco Imaging (Italy) Sales, Revenue and Gross Margin (2015-2020)
- 11.2.4 Bracco Imaging (Italy) Oral Contrast Agent Products Offered
- 11.2.5 Bracco Imaging (Italy) Related Developments
- 11.3 Bayer HealthCare (Germany)
- 11.3.1 Bayer HealthCare (Germany) Corporation Information
- 11.3.2 Bayer HealthCare (Germany) Description and Business Overview
- 11.3.3 Bayer HealthCare (Germany) Sales, Revenue and Gross Margin (2015-2020)
- 11.3.4 Bayer HealthCare (Germany) Oral Contrast Agent Products Offered
- 11.3.5 Bayer HealthCare (Germany) Related Developments
- 11.4 Guerbet (France)
- 11.4.1 Guerbet (France) Corporation Information
- 11.4.2 Guerbet (France) Description and Business Overview
- 11.4.3 Guerbet (France) Sales, Revenue and Gross Margin (2015-2020)
- 11.4.4 Guerbet (France) Oral Contrast Agent Products Offered
- 11.4.5 Guerbet (France) Related Developments
- 11.5 Lantheus (US)
- 11.5.1 Lantheus (US) Corporation Information
- 11.5.2 Lantheus (US) Description and Business Overview
- 11.5.3 Lantheus (US) Sales, Revenue and Gross Margin (2015-2020)
- 11.5.4 Lantheus (US) Oral Contrast Agent Products Offered
- 11.5.5 Lantheus (US) Related Developments
- 11.6 Daiichi Sankyo (Japan)
- 11.6.1 Daiichi Sankyo (Japan) Corporation Information
- 11.6.2 Daiichi Sankyo (Japan) Description and Business Overview
- 11.6.3 Daiichi Sankyo (Japan) Sales, Revenue and Gross Margin (2015-2020)
- 11.6.4 Daiichi Sankyo (Japan) Oral Contrast Agent Products Offered
- 11.6.5 Daiichi Sankyo (Japan) Related Developments
- 11.7 Unijules Life Sciences (India)
- 11.7.1 Unijules Life Sciences (India) Corporation Information
- 11.7.2 Unijules Life Sciences (India) Description and Business Overview
- 11.7.3 Unijules Life Sciences (India) Sales, Revenue and Gross Margin (2015-2020)
- 11.7.4 Unijules Life Sciences (India) Oral Contrast Agent Products Offered
- 11.7.5 Unijules Life Sciences (India) Related Developments
- 11.8 J.B. Chemicals and Pharmaceuticals (India)
- 11.8.1 J.B. Chemicals and Pharmaceuticals (India) Corporation Information
- 11.8.2 J.B. Chemicals and Pharmaceuticals (India) Description and Business Overview
- 11.8.3 J.B. Chemicals and Pharmaceuticals (India) Sales, Revenue and Gross Margin (2015-2020)
- 11.8.4 J.B. Chemicals and Pharmaceuticals (India) Oral Contrast Agent Products Offered
- 11.8.5 J.B. Chemicals and Pharmaceuticals (India) Related Developments
- 11.9 Spago Nanomedicine (Sweden)
- 11.9.1 Spago Nanomedicine (Sweden) Corporation Information
- 11.9.2 Spago Nanomedicine (Sweden) Description and Business Overview
- 11.9.3 Spago Nanomedicine (Sweden) Sales, Revenue and Gross Margin (2015-2020)
- 11.9.4 Spago Nanomedicine (Sweden) Oral Contrast Agent Products Offered
- 11.9.5 Spago Nanomedicine (Sweden) Related Developments
- 11.10 Taejoon Pharm (South Korea)
- 11.10.1 Taejoon Pharm (South Korea) Corporation Information
- 11.10.2 Taejoon Pharm (South Korea) Description and Business Overview
- 11.10.3 Taejoon Pharm (South Korea) Sales, Revenue and Gross Margin (2015-2020)
- 11.10.4 Taejoon Pharm (South Korea) Oral Contrast Agent Products Offered
- 11.10.5 Taejoon Pharm (South Korea) Related Developments
- 11.1 GE Healthcare (US)
- 11.1.1 GE Healthcare (US) Corporation Information
- 11.1.2 GE Healthcare (US) Description and Business Overview
- 11.1.3 GE Healthcare (US) Sales, Revenue and Gross Margin (2015-2020)
- 11.1.4 GE Healthcare (US) Oral Contrast Agent Products Offered
- 11.1.5 GE Healthcare (US) Related Developments
- 11.12 Magnus Health (India)
- 11.12.1 Magnus Health (India) Corporation Information
- 11.12.2 Magnus Health (India) Description and Business Overview
- 11.12.3 Magnus Health (India) Sales, Revenue and Gross Margin (2015-2020)
- 11.12.4 Magnus Health (India) Products Offered
- 11.12.5 Magnus Health (India) Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
- 12.1 Oral Contrast Agent Market Estimates and Projections by Region
- 12.1.1 Global Oral Contrast Agent Sales Forecast by Regions 2021-2026
- 12.1.2 Global Oral Contrast Agent Revenue Forecast by Regions 2021-2026
- 12.2 North America Oral Contrast Agent Market Size Forecast (2021-2026)
- 12.2.1 North America: Oral Contrast Agent Sales Forecast (2021-2026)
- 12.2.2 North America: Oral Contrast Agent Revenue Forecast (2021-2026)
- 12.2.3 North America: Oral Contrast Agent Market Size Forecast by Country (2021-2026)
- 12.3 Europe Oral Contrast Agent Market Size Forecast (2021-2026)
- 12.3.1 Europe: Oral Contrast Agent Sales Forecast (2021-2026)
- 12.3.2 Europe: Oral Contrast Agent Revenue Forecast (2021-2026)
- 12.3.3 Europe: Oral Contrast Agent Market Size Forecast by Country (2021-2026)
- 12.4 Asia Pacific Oral Contrast Agent Market Size Forecast (2021-2026)
- 12.4.1 Asia Pacific: Oral Contrast Agent Sales Forecast (2021-2026)
- 12.4.2 Asia Pacific: Oral Contrast Agent Revenue Forecast (2021-2026)
- 12.4.3 Asia Pacific: Oral Contrast Agent Market Size Forecast by Region (2021-2026)
- 12.5 Latin America Oral Contrast Agent Market Size Forecast (2021-2026)
- 12.5.1 Latin America: Oral Contrast Agent Sales Forecast (2021-2026)
- 12.5.2 Latin America: Oral Contrast Agent Revenue Forecast (2021-2026)
- 12.5.3 Latin America: Oral Contrast Agent Market Size Forecast by Country (2021-2026)
- 12.6 Middle East and Africa Oral Contrast Agent Market Size Forecast (2021-2026)
- 12.6.1 Middle East and Africa: Oral Contrast Agent Sales Forecast (2021-2026)
- 12.6.2 Middle East and Africa: Oral Contrast Agent Revenue Forecast (2021-2026)
- 12.6.3 Middle East and Africa: Oral Contrast Agent Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
- 13.1 Market Opportunities and Drivers
- 13.2 Market Challenges
- 13.3 Market Risks/Restraints
- 13.4 Porter's Five Forces Analysis
- 13.5 Primary Interviews with Key Oral Contrast Agent Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
- 14.1 Value Chain Analysis
- 14.2 Oral Contrast Agent Customers
- 14.3 Sales Channels Analysis
- 14.3.1 Sales Channels
- 14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
- 16.1 Research Methodology
- 16.1.1 Methodology/Research Approach
- 16.1.2 Data Source
- 16.2 Author Details
Summary:
Get latest Market Research Reports on Oral Contrast Agent. Industry analysis & Market Report on Oral Contrast Agent is a syndicated market report, published as Global (United States, European Union and China) Oral Contrast Agent Market Research Report 2019-2025. It is complete Research Study and Industry Analysis of Oral Contrast Agent market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
